Clinical trials
Phase 3 Major Depressive Disorder trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 1 |
| 2008 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 3 |
| 2017 | 1 |
| 2018 | 1 |
| 2022 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 5 |
| Terminated | 3 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alkermes, Inc. | 4 |
| Eli Lilly and Company | 4 |
| AstraZeneca | 2 |
| Cybin IRL Limited | 2 |
| Janssen Research & Development, LLC | 2 |
| Takeda | 2 |
| GlaxoSmithKline | 1 |
| Neurocrine Biosciences | 1 |
| Otsuka Pharmaceutical Co., Ltd. | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 21 |
| Depressive Disorder | 5 |
| Mood Disorders | 4 |
| Anhedonia | 1 |
| Anxiety Disorders | 1 |
| Combat Disorders | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Dysthymic Disorder | 1 |
| Mental Disorders | 1 |
| Stress Disorders, Post-Traumatic | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.